This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Evaluation of the ProstaPlant Prostate Stent Insertion in Ex Vivo Human Prostate

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2007 by ProstaPlant Urology System Ltd..
Recruitment status was:  Not yet recruiting
Information provided by:
ProstaPlant Urology System Ltd. Identifier:
First received: April 30, 2007
Last updated: NA
Last verified: March 2007
History: No changes posted
The purpose of this ex-vivo study is to evaluate the insertion procedure for the ProstaPlant implant in human prostates and the support that it supplies to the prostate.

Condition Intervention Phase
Benign Prostatic Hyperplasia Device: ProstaPlant Stent Phase 1

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by ProstaPlant Urology System Ltd.:

Primary Outcome Measures:
  • This is a feasibility study, in which initial evaluation of stent insertion procedure is obtained


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male

Inclusion Criteria:

  • Males,
  • 18 years old and up,
  • Suffer from BPH,
  • Candidate for radical prostatectomies

Exclusion Criteria:

  • According to the physician's decision
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00468026

Contact: Jack Baniel, Prof. 972-3-9376563

"Asuta" Medical Center Not yet recruiting
Tel-Aviv, Israel, 62748
Contact: Jack Baniel, Prof.    972-3-9376563      
Sub-Investigator: David Margel, Dr.         
Sub-Investigator: Miriam Konichevky, Dr.         
Sponsors and Collaborators
ProstaPlant Urology System Ltd.
Principal Investigator: Jack Baniel, Prof. "Rabin" Medical Center - "Belinson" Campus - Urology Department
  More Information Identifier: NCT00468026     History of Changes
Other Study ID Numbers: Human Ex-Vivo - V001-3.2007
Study First Received: April 30, 2007
Last Updated: April 30, 2007

Keywords provided by ProstaPlant Urology System Ltd.:
Benign prostatic hyperplasia (BPH)

Additional relevant MeSH terms:
Prostatic Hyperplasia
Pathologic Processes
Prostatic Diseases
Genital Diseases, Male processed this record on September 19, 2017